Kidney Clearance of Secretory Solutes Is Associated with Progression of CKD: The CRIC Study.

BACKGROUND The secretion of organic solutes by the proximal tubules is an essential intrinsic kidney function. However, the clinical significance of the kidney's clearance of tubular secretory solutes is uncertain. METHODS In this prospective cohort study, we evaluated 3416 participants with CKD from the Chronic Renal Insufficiency Cohort (CRIC) study. We measured plasma and 24-hour urine concentrations of endogenous candidate secretory solutes at baseline, using targeted liquid chromatography-tandem mass spectrometry. The study defined CKD progression by a ≥50% decline in the eGFR, initiation of maintenance dialysis, or kidney transplantation. We used Cox proportional hazards regression to test associations of secretory-solute clearances with CKD progression and mortality, adjusting for eGFR, albuminuria, and other confounding characteristics. RESULTS Participants in this ancillary study had a mean age of 58 years and 41% were black; the median eGFR was 43 ml/min per 1.73 m2. After adjustment, lower kidney clearances of six solutes-kynurenic acid, pyridoxic acid, indoxyl sulfate, xanthosine, isovalerylglycine, and cinnamoylglycine-were associated with significantly greater risks of CKD progression, with clearance of kynurenic acid, a highly protein-bound solute, having the strongest association. Lower clearances of isovalerylglycine, tiglylglycine, hippurate, and trimethyluric acid were significantly associated with all-cause mortality after adjustment. CONCLUSIONS We found lower kidney clearances of endogenous secretory solutes to be associated with CKD progression and all-cause mortality, independent of eGFR and albuminuria. This suggests that tubular clearance of secretory solutes provides additional information about kidney health beyond measurements of glomerular function alone.

[1]  N. Shinomiya,et al.  Identification of ABCG2 as an Exporter of Uremic Toxin Indoxyl Sulfate in Mice and as a Crucial Factor Influencing CKD Progression , 2018, Scientific Reports.

[2]  C. Investigators Self-reported Medication Adherence and CKD Progression , 2018 .

[3]  J. Perl,et al.  Extended Duration Nocturnal Hemodialysis and Changes in Plasma Metabolite Profiles. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[4]  Anna C. Porter,et al.  Self-reported Medication Adherence and CKD Progression , 2018, Kidney international reports.

[5]  Wei Wu,et al.  The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut–liver–kidney axis , 2017, The Journal of Biological Chemistry.

[6]  Mahboob Rahman,et al.  Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[7]  G. Beck,et al.  Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial. , 2017, Kidney international.

[8]  B. Kestenbaum,et al.  Diurnal and Long-term Variation in Plasma Concentrations and Renal Clearances of Circulating Markers of Kidney Proximal Tubular Secretion. , 2017, Clinical chemistry.

[9]  T. Meyer,et al.  Tubular Secretion in CKD. , 2016, Journal of the American Society of Nephrology : JASN.

[10]  R. Blantz,et al.  Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[11]  J. Wetzels,et al.  Proximal tubular efflux transporters involved in renal excretion of p-cresyl sulfate and p-cresyl glucuronide: Implications for chronic kidney disease pathophysiology. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.

[12]  Don C Rockey,et al.  Fibrosis--a common pathway to organ injury and failure. , 2015, The New England journal of medicine.

[13]  T. Niwa,et al.  Indoxyl sulfate upregulates prorenin expression via nuclear factor-κB p65, signal transducer and activator of transcription 3, and reactive oxygen species in proximal tubular cells. , 2015, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[14]  Yi‐Jen Chen,et al.  The Uremic Toxin Indoxyl Sulfate Increases Pulmonary Vein and Atrial Arrhythmogenesis , 2015, Journal of cardiovascular electrophysiology.

[15]  Sanjay K. Nigam,et al.  What do drug transporters really do? , 2014, Nature Reviews Drug Discovery.

[16]  T. Abe,et al.  The kidney and uremic toxin removal: glomerulus or tubule? , 2014, Seminars in nephrology.

[17]  Mahboob Rahman,et al.  Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  L. P. Van den Heuvel,et al.  Hyperuricemia influences tryptophan metabolism via inhibition of multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP). , 2013, Biochimica et biophysica acta.

[19]  R. Vasan,et al.  A combined epidemiologic and metabolomic approach improves CKD prediction. , 2013, Journal of the American Society of Nephrology : JASN.

[20]  T. Meyer,et al.  Numerous protein-bound solutes are cleared by the kidney with high efficiency , 2013, Kidney international.

[21]  M. Joffe,et al.  Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  Harold I Feldman,et al.  Estimating glomerular filtration rate from serum creatinine and cystatin C. , 2012, The New England journal of medicine.

[23]  Raymond Vanholder,et al.  Normal and pathologic concentrations of uremic toxins. , 2012, Journal of the American Society of Nephrology : JASN.

[24]  H. Feldman,et al.  Measured GFR does not outperform estimated GFR in predicting CKD-related complications. , 2011, Journal of the American Society of Nephrology : JASN.

[25]  F. Leblond,et al.  Effects of Chronic Renal Failure on Kidney Drug Transporters and Cytochrome P450 in Rats , 2011, Drug Metabolism and Disposition.

[26]  A. Go,et al.  Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[27]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[28]  R. Unwin,et al.  The Not So ‘Mighty Chondrion’: Emergence of Renal Diseases due to Mitochondrial Dysfunction , 2006, Nephron Physiology.

[29]  S. Fukuhara,et al.  Health-Related Quality of Life of Predialysis Patients with Chronic Renal Failure , 2006, Nephron Clinical Practice.

[30]  Y. Takekuma,et al.  Structure-affinity relationship in the interactions of human organic anion transporter 1 with caffeine, theophylline, theobromine and their metabolites. , 2005, Biochimica et biophysica acta.

[31]  H. Endou,et al.  Altered renal elimination of organic anions in rats with chronic renal failure. , 2005, Biochimica et biophysica acta.

[32]  T. Akizawa,et al.  Protective Effect of an Oral Adsorbent on Renal Function in Chronic Renal Failure: Determinants of its Efficacy in Diabetic Nephropathy , 2004, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[33]  H. Koepsell,et al.  The SLC22 drug transporter family , 2004, Pflügers Archiv.

[34]  J. Felmlee,et al.  Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease. , 2003, Kidney international.

[35]  A. Go,et al.  The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. , 2003, Journal of the American Society of Nephrology : JASN.

[36]  R. Gans,et al.  C-reactive protein is associated with renal function abnormalities in a non-diabetic population. , 2003, Kidney international.

[37]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[38]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[39]  K. Nath,et al.  Tubulointerstitial changes as a major determinant in the progression of renal damage. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[40]  G. Hommel A stagewise rejective multiple test procedure based on a modified Bonferroni test , 1988 .

[41]  Wei Wu,et al.  The organic anion transporter (OAT) family: a systems biology perspective. , 2015, Physiological reviews.

[42]  Brenda R. Hemmelgarn,et al.  Notice , 2012, Kidney International Supplements.

[43]  Mai-Szu Wu,et al.  p-Cresol sulfate and indoxyl sulfate induce similar cellular inflammatory gene expressions in cultured proximal renal tubular cells. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[44]  J. Stockman,et al.  A New Equation to Estimate Glomerular Filtration Rate , 2011 .

[45]  A. Levin,et al.  Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. , 2007, Kidney international.